BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 20959409)

  • 1. Varying opinions on the authenticity of a human midgut carcinoid cell line--letter.
    Ellis LM; Samuel S; Sceusi E
    Clin Cancer Res; 2010 Nov; 16(21):5365-6. PubMed ID: 20959409
    [No Abstract]   [Full Text] [Related]  

  • 2. Small intestinal neuroendocrine cell pathobiology: 'carcinoid' tumors.
    Kidd M; Modlin IM
    Curr Opin Oncol; 2011 Jan; 23(1):45-52. PubMed ID: 21045686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression in midgut carcinoid tumors: potential targets for immunotherapy.
    Vikman S; Essand M; Cunningham JL; de la Torre M; Oberg K; Tötterman TH; Giandomenico V
    Acta Oncol; 2005; 44(1):32-40. PubMed ID: 15848904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignancy-associated allelic losses on the X-chromosome in foregut but not in midgut endocrine tumours.
    Pizzi S; D'Adda T; Azzoni C; Rindi G; Grigolato P; Pasquali C; Corleto VD; Delle Fave G; Bordi C
    J Pathol; 2002 Apr; 196(4):401-7. PubMed ID: 11920735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood transcript analysis and metastatic recurrent small bowel carcinoid management.
    Modlin IM; Drozdov I; Bodei L; Kidd M
    BMC Cancer; 2014 Aug; 14():564. PubMed ID: 25095873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumours of the midgut (jejunum, ileum and ascending colon, including carcinoid syndrome).
    de Herder WW
    Best Pract Res Clin Gastroenterol; 2005 Oct; 19(5):705-15. PubMed ID: 16253895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The development and characterization of a human midgut carcinoid cell line.
    Van Buren G; Rashid A; Yang AD; Abdalla EK; Gray MJ; Liu W; Somcio R; Fan F; Camp ER; Yao JC; Ellis LM
    Clin Cancer Res; 2007 Aug; 13(16):4704-12. PubMed ID: 17699847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A carcinoid tumor of the stomach with features of a midgut tumor.
    Quinonez G; Ragbeer MS; Simon GT
    Arch Pathol Lab Med; 1988 Aug; 112(8):838-41. PubMed ID: 3395222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial small-intestine carcinoids: Chromosomal alterations and germline inositol polyphosphate multikinase sequencing.
    de Mestier L; Pasmant E; Fleury C; Brixi H; Sohier P; Féron T; Diebold MD; Clauser E; Cadiot G;
    Dig Liver Dis; 2017 Jan; 49(1):98-102. PubMed ID: 27825921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticancer activity of novel plant extracts from Trailliaedoxa gracilis (W. W. Smith & Forrest) in human carcinoid KRJ-I Cells.
    Svejda B; Aguiriano-Moser V; Sturm S; Höger H; Ingolic E; Siegl V; Stuppner H; Pfragner R
    Anticancer Res; 2010 Jan; 30(1):55-64. PubMed ID: 20150617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early invasiveness characterizes metastatic carcinoid tumors in transgenic mice.
    Grant SG; Seidman I; Hanahan D; Bautch VL
    Cancer Res; 1991 Sep; 51(18):4917-23. PubMed ID: 1654206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of heterozygosity in 11q13-14 regions in gastric neuroendocrine tumors not associated with multiple endocrine neoplasia type 1 syndrome.
    D'Adda T; Keller G; Bordi C; Höfler H
    Lab Invest; 1999 Jun; 79(6):671-7. PubMed ID: 10378509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic impact of DNA-image-cytometry in neuroendocrine (carcinoid) tumours.
    Petersen I
    Cell Oncol; 2006; 28(3):117-8; author reply 119-20. PubMed ID: 16823180
    [No Abstract]   [Full Text] [Related]  

  • 14. Microsatellite instability and gene mutations in transforming growth factor-beta type II receptor are absent in small bowel carcinoid tumors.
    Kidd M; Eick G; Shapiro MD; Camp RL; Mane SM; Modlin IM
    Cancer; 2005 Jan; 103(2):229-36. PubMed ID: 15599934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of platelet-derived growth factor and its receptors in neuroendocrine tumors of the digestive system.
    Chaudhry A; Papanicolaou V; Oberg K; Heldin CH; Funa K
    Cancer Res; 1992 Feb; 52(4):1006-12. PubMed ID: 1310635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of survival between malignant neuroendocrine tumours of midgut and pancreatic origin.
    Johanson V; Tisell LE; Olbe L; Wängberg B; Nilsson O; Ahlman H
    Br J Cancer; 1999 Jun; 80(8):1259-61. PubMed ID: 10376980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A TNM classification for digestive endocrine tumors of midgut and hindgut: proposals from the European Neuroendocrine Tumor Society (ENETS)].
    Couvelard A; Scoazec JY
    Ann Pathol; 2007 Dec; 27(6):426-32. PubMed ID: 18554552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Value of various neuroendocrine cell markers in the immunohistochemical diagnosis of neuroendocrine tumors of the gastroenteropancreatic system].
    Wirnsberger G; Höfler H
    Verh Dtsch Ges Pathol; 1987; 71():290-3. PubMed ID: 3326335
    [No Abstract]   [Full Text] [Related]  

  • 19. Primary hepatic endocrinomas (carcinoids and variant neoplasms). A statistical evaluation of 126 reported cases.
    Soga J
    J Exp Clin Cancer Res; 2002 Dec; 21(4):457-68. PubMed ID: 12636090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations of the SDHD gene locus in midgut carcinoids.
    Lima J; Máximo V; Soares P; Sobrinho-Simões M
    Genes Chromosomes Cancer; 2003 Apr; 36(4):424. PubMed ID: 12619155
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.